Neuland Laboratories Ltd Share Price

Overview

Neuland Laboratories Ltd share price is currently ₹22,799.77, up by ₹157.21 (0.69%) from its previous closing price of ₹22,642.56. The share price has gained 21.91% over the past month and gained 70.66% over the past year. The stock's 52-week low and high are ₹11,381.66 and ₹23,664.50, respectively. Neuland Laboratories Ltd has a market capitalisation of ₹ 29,890.00 Cr. The share price was last updated on 25 Aug 2026, 03:29 PM IST.

Neuland Laboratories Ltd

NEULANDLAB

₹0.00

₹157.21

0.69%

Healthcare

₹0.00(%)1D

Updated: 25 Aug 2026, 03:29:57 pm IST

Market Data

Open Price

₹22,710.86

Prev. Close

₹22,642.56

₹22,443.82

Day Low

₹22,855.48

Day High

₹11,381.66

52 Week Low

₹23,664.50

52 Week High

HealthcarePharmaceuticals & Drugs

CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

59.09

Sector PE

42.03

PB Ratio

15.61

Sector PB

5.83

EPS

385.86

Dividend Yield

0.28

Today's Volume

37.543 K

5 Day Avg. Volume

36.732 K

PEG Ratio

1.48

Market Cap.

₹ 29,890.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 340% at ₹34/Share	24-Jul-2026	24-Jul-2026
DividendsFinal Dividend of 120% at ₹12/Share	18-Jul-2025	18-Jul-2025

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
ICICI Prudential Flexicap Fund - Growth	2.26 Lac	2.26 Lac no change
HSBC Small Cap Fund - Regular Plan - Growth	1.62 Lac	1.62 Lac no change
HDFC Flexi Cap Fund - Growth	94.60 k	1.55 Lac (63.74%)
Mahindra Manulife Multi Cap Fund - Regular Plan - Growth	1.21 Lac	1.33 Lac (10.11%)
Mahindra Manulife Small Cap Fund - Regular Plan - Growth	86.45 k	1.03 Lac (19.61%)

Show all holdings

About Neuland Laboratories Ltd 👋

Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.